Research Output per year
Fingerprint Dive into the research topics where Eiichi Watanabe is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 9 Similar Profiles
Atrial Fibrillation
Medicine & Life Sciences
Heart Failure
Medicine & Life Sciences
Heart Rate
Medicine & Life Sciences
Warfarin
Medicine & Life Sciences
Electrocardiography
Medicine & Life Sciences
Myocardial Infarction
Medicine & Life Sciences
Hemorrhage
Medicine & Life Sciences
Mortality
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output 1995 2019
A decision tree-based survival analysis of patients with a history of inappropriate implantable cardioverter-defibrillator therapy
Yamamoto, M., Okajima, K., Shimane, A., Ozawa, T., Morishima, I., Asai, T., Takagi, M., Kasai, A., Fujii, E., Kiyono, K., Watanabe, E. & Ozaki, Y., 01-01-2019, In : International heart journal. 60, 2, p. 318-326 9 p.Research output: Contribution to journal › Article
Open Access
Decision Trees
Implantable Defibrillators
Survival Analysis
Decision Support Techniques
Therapeutics
Analysis of multiscale entropy characteristics of heart rate variability in patients with permanent atrial fibrillation for predicting ischemic stroke risk
Matsuoka, R., Yoshino, K., Watanabe, E. & Kiyono, K., 21-01-2019, Proceedings - 2018 IEEE International Conference on Bioinformatics and Biomedicine, BIBM 2018. Schmidt, H., Griol, D., Wang, H., Baumbach, J., Zheng, H., Callejas, Z., Hu, X., Dickerson, J. & Zhang, L. (eds.). Institute of Electrical and Electronics Engineers Inc., 1 p. 8621178. (Proceedings - 2018 IEEE International Conference on Bioinformatics and Biomedicine, BIBM 2018).Research output: Chapter in Book/Report/Conference proceeding › Conference contribution
Entropy
Atrial Fibrillation
Heart Rate
Stroke
Probability density function
Clinical experience of idarucizumab use in cases of cardiac tamponade under uninterrupted anticoagulation of dabigatran during catheter ablation of atrial fibrillation
Okishige, K., Yamauchi, Y., Hanaki, Y., Inoue, K., Tanaka, N., Yamaji, H., Murakami, T., Manita, M., Tabata, K., Ooie, T., Tatsukawa, Y., Sakai, H., Yamaki, M., Murakami, M., Takada, T., Osaka, Y., Ono, Y., Handa, K., Sugiyama, K., Yoshizawa, T. & 8 others, , 15-05-2019, In : Journal of Thrombosis and Thrombolysis. 47, 4, p. 487-494 8 p.Research output: Contribution to journal › Article
Cardiac Tamponade
Catheter Ablation
Atrial Fibrillation
Hemostasis
Anticoagulants
2
Citations
(Scopus)
Impact of serum albumin levels on supratherapeutic PT-INR control and bleeding risk in atrial fibrillation patients on warfarin: A prospective cohort study
Kawai, M., Harada, M., Motoike, Y., Koshikawa, M., Ichikawa, T., Watanabe, E. & Ozaki, Y., 01-03-2019, In : IJC Heart and Vasculature. 22, p. 111-116 6 p.Research output: Contribution to journal › Article
International Normalized Ratio
Warfarin
Serum Albumin
Atrial Fibrillation
Albumins
The presence of late potentials after percutaneous coronary intervention for the treatment of acute coronary syndrome as a predictor for future significant cardiac events resulting in re-hospitalization
Amino, M., Yoshioka, K., Ichikawa, T., Watanabe, E., Kiyono, K., Nakamura, M., Sakama, S., Ayabe, K., Fujii, T., Hashida, T., Kanda, S., Tanabe, T. & Ikari, Y., 01-03-2019, In : Journal of Electrocardiology. 53, p. 71-78 8 p.Research output: Contribution to journal › Article
Percutaneous Coronary Intervention
Acute Coronary Syndrome
Hospitalization
Electrocardiography
Therapeutics